Spivak-Kroizman TR - Search Results

1

Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer.

Spivak-Kroizman TR, Hostetter G, Posner R, Aziz M, Hu C, Demeure MJ, Von Hoff D, Hingorani SR, Palculict TB, Izzo J, Kiriakova GM, Abdelmelek M, Bartholomeusz G, James BP, Powis G. Spivak-Kroizman TR, et al. Cancer Res. 2013 Jun 1;73(11):3235-47. doi: 10.1158/0008-5472.CAN-11-1433. Epub 2013 Apr 30. Cancer Res. 2013. PMID: 23633488 Free PMC article.

2

Inhibiting the hypoxia response for cancer therapy: the new kid on the block.

Koh MY, Spivak-Kroizman TR, Powis G. Koh MY, et al. Among authors: spivak kroizman tr. Clin Cancer Res. 2009 Oct 1;15(19):5945-6. doi: 10.1158/1078-0432.CCR-09-1650. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789327 Free PMC article.

3

HIF-1alpha and cancer therapy.

Koh MY, Spivak-Kroizman TR, Powis G. Koh MY, et al. Among authors: spivak kroizman tr. Recent Results Cancer Res. 2010;180:15-34. doi: 10.1007/978-3-540-78281-0_3. Recent Results Cancer Res. 2010. PMID: 20033376 Review.

4

HIF-1 regulation: not so easy come, easy go.

Yee Koh M, Spivak-Kroizman TR, Powis G. Yee Koh M, et al. Among authors: spivak kroizman tr. Trends Biochem Sci. 2008 Nov;33(11):526-34. doi: 10.1016/j.tibs.2008.08.002. Epub 2008 Sep 21. Trends Biochem Sci. 2008. PMID: 18809331 Review.

5

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.

Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL, Powis G. Koh MY, et al. Mol Cancer Ther. 2008 Jan;7(1):90-100. doi: 10.1158/1535-7163.MCT-07-0463. Mol Cancer Ther. 2008. PMID: 18202012

6

TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.

Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T. Polek TC, et al. J Biol Chem. 2003 Aug 22;278(34):32317-23. doi: 10.1074/jbc.M302518200. Epub 2003 Jun 6. J Biol Chem. 2003. PMID: 12794080 Free article.

7

TRAIL-induced cleavage and inactivation of SPAK sensitizes cells to apoptosis.

Polek TC, Talpaz M, Spivak-Kroizman TR. Polek TC, et al. Among authors: spivak kroizman tr. Biochem Biophys Res Commun. 2006 Oct 27;349(3):1016-24. doi: 10.1016/j.bbrc.2006.08.118. Epub 2006 Aug 28. Biochem Biophys Res Commun. 2006. PMID: 16950202

8

The TNF receptor, RELT, binds SPAK and uses it to mediate p38 and JNK activation.

Polek TC, Talpaz M, Spivak-Kroizman T. Polek TC, et al. Biochem Biophys Res Commun. 2006 Apr 28;343(1):125-34. doi: 10.1016/j.bbrc.2006.02.125. Epub 2006 Mar 2. Biochem Biophys Res Commun. 2006. PMID: 16530727

9

Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells.

Spivak-Kroizman T, Mohammadi M, Hu P, Jaye M, Schlessinger J, Lax I. Spivak-Kroizman T, et al. J Biol Chem. 1994 May 20;269(20):14419-23. J Biol Chem. 1994. PMID: 7514169 Free article.

10

Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.

Spivak-Kroizman T, Rotin D, Pinchasi D, Ullrich A, Schlessinger J, Lax I. Spivak-Kroizman T, et al. J Biol Chem. 1992 Apr 25;267(12):8056-63. J Biol Chem. 1992. PMID: 1349015 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page